How IUDs Affect Your Period
IUDs can prevent pregnancy for up to 10 years. And while they go about their business, they can also change (even stop) your period. Here’s what you need to know.
Related Articles
Apple Intelligence so far: did Apple oversell it?
There’s still much more to come with Apple Intelligence.
CVS Health’s new app aims to be a one-stop shop for customers, members
CVS Health is rolling out a new customer app that aims to make it simpler and more convenient for users to manage health benefits, pharmacy…
Opioid Overdose Epidemic Podcast Series on AMA Ed Hub
Listen to expert discussions and insights to help PCPs and other HCPs address the epidemic of opioid overdoses. Learn about treatment options for pain management,…
Takeaways from RFK Jr.’s first day before Congress
This week in health care policy and politics news: The first RFK Jr. Senate hearings, and RFK Jr.’s private emails show vaccine criticism.
Trump administration’s halt of CDC’s weekly scientific report stalls bird flu studies | CNN
The Trump administration has intervened in the release of important studies on the bird flu, as an outbreak escalates across the United States.
Inside Pluton — Microsoft’s security processor that’s coming to a PC near you soon
Microsoft first announced its Pluton security processor as far back as 2020 and more recently has said it will be enabled by default on all…
NCPA: Independent pharmacies weigh stocking drugs under Medicare price negotiation
The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face significant financial hardship due to Medicare drug price…
FDA Approves Meloxicam and Rizatriptan (Symbravo) for Acute Migraine With or Without Aura
Axsome Therapeutics announced that the FDA approved the NDA for AXS-07 to treat acute migraine with or without aura on January 30, 2025.
Strengthening Nurses’ Influence in Health Policy : AJN The American Journal of Nursing
foundational guide to nurses’ self-assessment of their health policy actions. It includes three dimensions: engagement, partnership, and reach, each with three levels. The levels of…
GLP-1 agonists may raise risk of pulmonary aspiration during surgery, MHRA warns
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may increase the risk of pulmonary aspiration among patients undergoing surgery…
